TI
HRTX icon

Trexquant Investment’s Heron Therapeutics HRTX Stock Holding History

Trexquant Investment’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-51,695
Closed -$296K – 1657
2022
Q1 		$296K Sell
51,695
-2,109
-4% -$15.4K 0.01% 1010
2021
Q4 		$491K Buy
53,804
+15,650
+41% +$160K 0.03% 649
2021
Q3 		$408K Buy
38,154
+13,925
+57% +$170K 0.03% 617
2021
Q2 		$376K Sell
24,229
-4,164
-15% -$66.2K 0.03% 613
2021
Q1 		$460K Buy
+28,393
New +$506K 0.04% 547
2020
Q4 		– Sell
-72,449
Closed -$1.07M – 1219
2020
Q3 		$1.07M Buy
72,449
+44,364
+158% +$692K 0.07% 394
2020
Q2 		$413K Sell
28,085
-51,546
-65% -$847K 0.03% 744
2020
Q1 		$935K Buy
79,631
+31,980
+67% +$601K 0.07% 442
2019
Q4 		$1.12M Buy
+47,651
New +$1.05M 0.07% 343
2019
Q2 		– Sell
-70,639
Closed -$1.73M – 950
2019
Q1 		$1.73M Buy
+70,639
New +$1.85M 0.12% 247
2018
Q4 		– Sell
-21,408
Closed -$678K – 1144
2018
Q3 		$678K Sell
21,408
-4,048
-16% -$151K 0.05% 461
2018
Q2 		$989K Buy
+25,456
New +$810K 0.07% 378
2018
Q1 		– Sell
-51,907
Closed -$940K – 1207
2017
Q4 		$940K Buy
51,907
+39,131
+306% +$638K 0.1% 310
2017
Q3 		$206K Buy
+12,776
New +$200K 0.05% 625
2017
Q1 		– Sell
-26,915
Closed -$353K – 1182
2016
Q4 		$353K Buy
+26,915
New +$422K 0.06% 580
2016
Q1 		– Sell
-11,072
Closed -$296K – 1023
2015
Q4 		$296K Buy
+11,072
New +$296K 0.03% 854

Other funds holding HRTX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Trexquant Investment's HRTX Position: Q2 2022 in Review

Trexquant Investment sold out of Heron Therapeutics (HRTX) in Q2 2022, closing a stake of 51,695 shares — an estimated $296K sold.

Trexquant Investment first reported a position in HRTX in Q4 2015 and held it in 16 quarters. The position peaked at $1.73M in Q1 2019. 174 funds tracked by Wall St. Rank hold HRTX as of Q2 2022.

  • Trexquant Investment reported no remaining Heron Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Trexquant Investment sold 51,695 Heron Therapeutics shares in Q2 2022, an estimated $296K.
  • Trexquant Investment first reported a position in Heron Therapeutics in Q4 2015 and held it in 16 quarters.
  • Trexquant Investment's Heron Therapeutics position peaked at $1.73M in Q1 2019.
  • 174 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2022.

Based on Trexquant Investment's 13F filing for Q2 2022, filed 11 Aug 2022.